A. Mayumi-Aono

Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2.

S. Hinuma, Y. Fujisawa, M. Hazama, 1993, Immunology.

Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2.

S. Hinuma, S. Kuroda, Y. Fujisawa, 1993, Vaccine.

Immunotherapy of acute and recurrent herpes simplex virus type 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein.

S. Hinuma, Y. Fujisawa, M. Hazama, 1994, The Journal of infectious diseases.